NCT06725992View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

April 13, 2024

Study Completion Date

August 14, 2024

Conditions
PharmacokineticsPharmacodynamics
Interventions
DRUG

IY-NS250

Ilaprazole 20mg + Sodium bicarbonate 500mg

DRUG

IY-NT-SR

Ilaprazole 10mg

Trial Locations (1)

28644

Chungbuk National University Hospital, Seoul

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT06725992 - Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR | Biotech Hunter | Biotech Hunter